Literature DB >> 10071808

Surgical treatment of Boerhaave's syndrome: when, how and why?

K Liu1, Y J Wang, Q S Cheng, Q F Ma.   

Abstract

Ten cases of Boerhaave's syndrome have been treated in this hospital from 1983-1998. Nine patients underwent surgery resulting in complete recovery in seven cases and two postoperative deaths. One was treated with a satisfactory outcome. Vomiting was considered to be the determinative factor for the illness in eight cases. The relationship between the rupture of the esophagus and vomiting and the mechanism of its occurrence based on anatomy and pathophysiology is discussed. It is believed that the most beneficial time to perform surgery is based on the general condition of the patient. The surgical procedure should consist of closure of the lacerated esophagus, a complete clearance of the fibrinous coating on the surface of the pleura, mobilization of a pedicled omentum pad and a gastrostomy. The chest should be entered from the side where the esophagus was lacerated or the X-ray examination showed hydrothorax or hydropneumothorax. The most important factor to guarantee a successful outcome for surgery is a complete clear off of the empyema and early expansion of the lung in addition to effective nutritional support.

Entities:  

Mesh:

Year:  1998        PMID: 10071808     DOI: 10.1093/dote/11.4.251

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  2 in total

1.  Boerhaave's syndrome: primary repair vs. esophageal resection--case reports and meta-analysis of the literature.

Authors:  Otto Kollmar; Werner Lindemann; Sven Richter; Ingo Steffen; Georg Pistorius; Martin K Schilling
Journal:  J Gastrointest Surg       Date:  2003 Sep-Oct       Impact factor: 3.452

2.  Boerhaave's syndrome with late presentation. Experience in an Argentine single center: Case series.

Authors:  Daniel N Velasco Hernández; Héctor R Horiuchi; Lucas A Rivaletto; Fidelio Farina; Matías Viscuso
Journal:  Ann Med Surg (Lond)       Date:  2019-07-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.